Target intelligence / Profile preview

Basolateral potassium channel (cAMP-activated) (null (commonly KCNQ1, when referring to Kv7.1; sometimes called cAMP-regulated K⁺ channel or "basolateral K⁺ channel"))

Target
null (commonly KCNQ1, when referring to Kv7.1; sometimes called cAMP-regulated K⁺ channel or "basolateral K⁺ channel")
Molecular classification
Ion channel, Potassium channel, Voltage-gated potassium channel (Kv family, e.g., KCNQ/Kv7.1), Two-pore potassium channel (KCNK), Calcium-activated potassium channel (BK/Slo family, in some tissues)
01

Overview

cAMP-activated basolateral potassium channels are a group of ion channels located on the basolateral membrane of epithelial cells, especially in the kidney, that open in response to increased intracellular cAMP, typically via PKA signaling. These channels facilitate potassium recycling, helping maintain membrane potential and support sodium/potassium ATPase activity crucial for epithelial transport. The most direct molecular correlates are KCNQ1 (Kv7.1) channels and, in some contexts, BK (Slo1) channels. Their dysfunction is implicated in cardiac arrhythmias and renal transport disorders. Due to the diverse molecular families (Kv, KCNK, Slo, etc.), "cAMP-activated basolateral K⁺ channels" describes a physiological function, not a unique protein, and care should be taken to specify the molecular identity when relating to disease or drug targeting[4][5][1][3].

Other names
cAMP-regulated K⁺ channelsBasolateral K⁺ channelKv7.1 channel (KCNQ1)Renal epithelial K⁺ channelSlo1 channel (BK channel, less commonly cAMP-activated but found basolaterally in some contexts)
02

Mechanism of action

Direct channel blockade or open-state inhibition (e.g., XE991, linopirdine) Allosteric potentiation (some β-agonists via cAMP/PKA) Indirect trafficking regulation by cAMP/PKA (affecting membrane localization and expression density)

03

Biological functions

Regulation of membrane potentialPotassium ion recycling for Na⁺/K⁺-ATPase functionFacilitation of salt and water reabsorptionCell volume regulationSignal transduction in response to cAMP/PKA, especially in epithelial transport
04

Disease associations

Cardiovascular disease (e.g., arrhythmias due to KCNQ1 mutations)Renal disorders (mutations affect tubular transport)Channelopathies including long QT syndrome (KCNQ1)Other (potential roles in epilepsy, volume overload, polycystic kidney disease)
05

Safety considerations

Electrolyte imbalance (hypokalemia, hyperkalemia from improper modulation)Drug-induced arrhythmias (risk of long QT due to excessive inhibition)Renal handling disruptions (volume overload, hypertension)
06

Interacting drugs

K⁺ channel modulators such as XE991, linopirdine (Kv7 inhibitors)

3 more in the full profile.

07

Biomarkers

ECG for long QT syndrome (KCNQ1-related arrhythmias)Mutational screening for channelopathy riskUrinary potassium excretion patterns (renal K⁺ channel dysfunction)

Beyond the preview

Go deeper on Basolateral potassium channel (cAMP-activated) (null (commonly KCNQ1, when referring to Kv7.1; sometimes called cAMP-regulated K⁺ channel or "basolateral K⁺ channel")).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Basolateral potassium channel (cAMP-activated) (null (commonly KCNQ1, when referring to Kv7.1; sometimes called cAMP-regulated K⁺ channel or "basolateral K⁺ channel")).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call